JUL 04, 2019 3:39 PM PDT

Combination Therapy Eliminates HIV From Rodent Model

WRITTEN BY: Carmen Leitch

In 2017, 1.8 million new cases of HIV infection were diagnosed around the world, and around 37 million people now live with the virus. Researchers have made progress in the treatment and prevention of HIV infections, but it is still considered an epidemic. Now scientists have taken another step towards a potential cure for this deadly illness. A team of researchers from Temple University and the University of Nebraska Medical Center (UNMC) was able to eliminate HIV-1 viral DNA that can produce more virus, from live animal genomes. The work has been reported in Nature Communications.

A scanning electron microscopic (SEM) image showing numerous human immunodeficiency virus-1 (HIV-1) virions budding from a cultured lymphocyte / Credit: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus

"Our study shows that treatment to suppress HIV replication and gene editing therapy, when given sequentially, can eliminate HIV from cells and organs of infected animals," said Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Neuroscience and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz School of Medicine at Temple University.

HIV is a retrovirus; its genome is made of RNA, and an enzyme changes that RNA to DNA and inserts it into the genome of an infected host cell. The standard treatment for HIV is antiretroviral therapy (ART).

ART cannot remove the virus from the body, but it can reduce the proliferation of the virus and dramatically reduce the likelihood that others will be infected. Since it is not a cure, it must be taken by an affected individual for life, and like any medicine, it causes side effects. If a patient stops taking it, the virus easily rebounds and may progress to AIDS. The virus can rebound in part because it's integrated itself into the host cell’s genome, where drugs can’t get to it.

The CRISPR/Cas9 tool was created a few years ago as a gene editing system, and it’s had a major impact in many areas. Khalili and colleagues have previously used CRISPR/Cas9 to excise HIV DNA from genomes. They were able to do so in infected cells in rodent models, which had a significant impact on viral gene expression. But it does not remove HIV completely.

In this work, the CRISPR strategy was combined with a therapeutic technique called long-acting slow-effective release (LASER) ART, which was recently created by UNMC’s Howard Gendelman, MD, Chair of the Department of Pharmacology and Experimental Neuroscience and Benson Edagwa, Ph.D., Assistant Professor of Pharmacology. Hear more about the new tool in the video.

LASER ART packaged a modified antiretroviral drug into a nanocrystal so it would reach the areas of the body where it was needed, and stay active for a long time. It can help target the reservoirs that enable the virus to hang around in the body and displays few side effects.

"We wanted to see whether LASER ART could suppress HIV replication long enough for CRISPR/Cas9 to completely rid cells of viral DNA," said Khalili. The researchers tested their new combination therapy in a mouse model that recapitulated a latent viral infection. After treatment with LASER ART followed by CRISPR/Cas9,  the virus had been totally eliminated from about one-third of the group.

"The big message of this work is that it takes both CRISPR/Cas9 and virus suppression through a method such as LASER ART, administered together, to produce a cure for HIV infection," explained Khalili. "We now have a clear path to move ahead to trials in non-human primates and possibly clinical trials in human patients within the year."

 

Sources: Science Daily via Temple University, Nature Communications

Useful Resource: LendEDU

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 06, 2022
Genetics & Genomics
Reduced A-to-I Editing in RNA Linked to Autoimmune Disorder Risk
SEP 06, 2022
Reduced A-to-I Editing in RNA Linked to Autoimmune Disorder Risk
The genome contains the sequences for protein-coding genes, but before those seuquences are translated into protein, the ...
SEP 18, 2022
Cell & Molecular Biology
A New Kind of Human Cell for Research
SEP 18, 2022
A New Kind of Human Cell for Research
It is extremely challenging to study human development. There are animal models that can tell us how general aspects of ...
OCT 24, 2022
Neuroscience
Why is the Risk of Alzheimer's Higher in Women?
OCT 24, 2022
Why is the Risk of Alzheimer's Higher in Women?
Women tend to get Alzheimer's disease at a significantly higher rate than men; about two-thirds of people with the neuro ...
OCT 14, 2022
Drug Discovery & Development
Experimental Gene Therapy Restores Night Vision in Blind Patients
OCT 14, 2022
Experimental Gene Therapy Restores Night Vision in Blind Patients
Adults with a hereditary form of childhood-onset blindness experienced dramatic improvements in night vision within days ...
NOV 09, 2022
Drug Discovery & Development
Neanderthal Genes Risk Causing Toxicity with Common Drugs
NOV 09, 2022
Neanderthal Genes Risk Causing Toxicity with Common Drugs
While the Neandertals have gone extinct, their DNA still lingers in the genome of modern humans, where it can help or ha ...
NOV 16, 2022
Coronavirus
Divergent SARS-CoV-2 Variant Reveals Evidence of Deer-to-Human Transmission
NOV 16, 2022
Divergent SARS-CoV-2 Variant Reveals Evidence of Deer-to-Human Transmission
After only a few months of the COVID-19 pandemic, researchers had identified the virus that causes the disease, SARS-CoV ...
Loading Comments...